Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Sherry Korczynski
9 Sep 2026
Chief Commercial Officer
Sold after exercise
8,750
$5.22
$45.68K
Julie Krop
23 Jun 2026
Director
Sold after exercise
25,000
$5.02
$125.39K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 2
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,040,703
History held since 26 Jul 2018